RT Journal Article SR Electronic T1 Epidemiological dynamics of enterovirus D68 in the US: implications for acute flaccid myelitis JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.07.23.20069468 DO 10.1101/2020.07.23.20069468 A1 Sang Woo Park A1 Jeremy Farrar A1 Kevin Messacar A1 Lindsay Meyers A1 Margarita Pons-Salort A1 Bryan T. Grenfell YR 2020 UL http://medrxiv.org/content/early/2020/07/29/2020.07.23.20069468.abstract AB The lack of active surveillance for enterovirus D68 (EV-D68) in the US has hampered the ability to assess the relationship with predominantly biennial epidemics of acute flaccid myelitis (AFM), a rare but serious neurological condition. Using novel surveillance data from the BioFireĀ® Syndromic Trends (Trend) epidemiology network, we characterize the epidemiological dynamics of EV-D68 and demonstrate strong spatiotemporal association with AFM. Although the recent dominant biennial cycles of EV-D68 dynamics may not be stable, we show that a major EV-D68 epidemic, and hence an AFM outbreak, would still be possible in 2020 under normal epidemiological conditions. Significant social distancing due to the ongoing COVID-19 pandemic could reduce the size of an EV-D68 epidemic in 2020, illustrating the potential broader epidemiological impact of the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKM receives grant support from NIAID (Grant Number K23AI128069). MP-S is a Sir Henry Dale Fellow jointly funded by the Wellcome Trust and the Royal Society (Grant Number 216427/Z/19/Z).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this study has been aggregated to further protect both the privacy of the patient for publication and the identity of the contributing institutions. Access to data used in the study may be made available upon request.